Cytosorbents Cor (CTSO) 0.1950 $CTSO CytoSorbents to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cytosorbents Cor (CTSO) 0.1950 $CTSO

CytoSorbents to Report Fiscal 2013 Operating and Financial Results
PR Newswire - Tue Mar 25, 6:00AM CDT
CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb® blood filter to treat life-threatening illnesses in the intensive care unit, will report fiscal 2013 financial results after the market close on Monday, March 31, 2014.

CytoSorbents to Sponsor CytoSorb® Research Symposium at ISICEM 2014
PR Newswire - Thu Mar 13, 5:00AM CDT
CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using blood purification to treat life-threatening illnesses in the intensive care unit, announced that it will sponsor a research symposium entitled:

CytoSorbents Corporation Announces $10,200,000 Registered Direct Offering
PR Newswire - Fri Mar 07, 8:31AM CST
CytoSorbents Corporation (OTCBB: CTSO), a Nevada corporation, today announced that it has entered into subscription agreements with certain institutional investors to sell approximately $10,200,000 of its common stock and warrants to purchase common stock in a registered direct offering.

Vista Partners Publishes March 2014 Macroeconomic & Investment Newsletter
Marketwire - Fri Mar 07, 8:00AM CST
Vista Partners ("Vista") announced today that it published its FREE Macroeconomic & Investment Monthly Newsletter for the month of March. Each monthly newsletter from Vista contains macroeconomic thoughts from Principal Analyst Ross Silver, investment considerations, monthly highlights of each covered company and other broad based commentary.

National Institutes of Health Grant Urges Latino Males to Receive Free Confidential HIV Testing
PR Newswire - Wed Jan 29, 7:30AM CST
Today marks the launch of "Conoces a Pepe? Have you met Pepe?," a social impact campaign focusing on educating and mobilizing Hispanic/Latino communities to live their best life with HIV testing and taking responsibility for their health.

Stryker Hits 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 9:20AM CST
Shares of Stryker Corporation were favorably affected by its announcement of acquiring Irvine, Calif.-based Patient Safety Technologies

CytoSorbents to Exhibit at the 43rd Society of Critical Care Medicine Congress and Present at the Biotech Showcase 2014
Marketwire - Tue Jan 07, 8:01AM CST
CytoSorbents Corporation (OTCBB: CTSO), a critical care immunotherapy company, announced that it will exhibit its CytoSorb(R) and HemoDefend(TM) technologies at the Society of Critical Care Medicine (SCCM) 43rd Critical Care Congress from January 10-12, 2014 at the Moscone Center South in San Francisco, California in Booth 918. More than 4,000 critical care clinicians from the U.S. and abroad are expected to attend.

CytoSorbents Reports on Successful DIVI 2013 Conference
Marketwire - Mon Dec 16, 7:31AM CST
CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company commercializing its European Union approved CytoSorb(R) blood filter to treat life-threatening illnesses in the intensive care unit, reports on its recent activities at the DIVI 2013 Congress in Leipzig, Germany.

Biocon Partners With CytoSorbents to Market CytoSorb(R) -- A 'First-in-Class' Therapy for Sepsis Management
Marketwire - Fri Sep 13, 7:01AM CDT
Biocon Ltd, Asia's largest biotech company, and CytoSorbents Corporation (OTCQB: CTSO), based in the United States, announced today, World Sepsis Day, that they have entered into a strategic partnership with an initial distribution agreement for India and select emerging markets, under which Biocon will have the exclusive commercialization rights for CytoSorb(R), a novel therapy for the management of sepsis.

Stop Sepsis. Save Lives. CytoSorbents Sponsors Global Sepsis Alliance and Sepsis Heroes in Honor of World Sepsis Day
Marketwire - Thu Sep 12, 5:00AM CDT
CytoSorbents Corporation (OTCQB: CTSO), a leading innovator in the use of blood purification to treat critical illnesses such as sepsis, is a proud sponsor of both the Global Sepsis Alliance and the Sepsis Heroes event hosted by the Sepsis Alliance tonight in New York City, in honor of the second annual World Sepsis Day tomorrow.

CytoSorbents Awarded $203K Phase I SBIR Contract from NHLBI/NIH for HemoDefend(TM)
Marketwire - Mon Sep 09, 11:45AM CDT
CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company specializing in blood purification, announced today that the National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded the Company a Phase I SBIR (Small Business Innovation Research) contract to further advance its HemoDefend(TM) blood purification technology for packed red blood cell (pRBC) transfusions. The project, entitled "Elimination of blood contaminants from pRBCs using HemoDefend hemocompatible porous polymer beads," is valued at $203,351 over 6 months, with funding to start immediately.

CytoSorbents to Present at the Rodman & Renshaw Annual Global Investment Conference
Marketwire - Wed Aug 28, 8:00AM CDT
CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company commercializing its European Union approved CytoSorb(R) blood filter to treat life-threatening illnesses in the intensive care unit, President and Chief Executive Officer, Dr. Phillip Chan will present at the Rodman & Renshaw Annual Global Investment Conference taking place on September 8-10 in New York City.

CytoSorbents Expands CytoSorb(R) Dosing Study to Eight Clinical Trial Sites
Marketwire - Wed Aug 21, 6:00AM CDT
CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company commercializing its European Union approved CytoSorb(R) blood filter to treat life-threatening illnesses in the intensive care unit, announced today the formal expansion of its CytoSorb(R) dosing study to eight leading clinical trial sites in Germany.

OTC Daily Alert Stock Watch - CytoSorbents (OTCQB: CTSO)
WorldStockWire - Thu Aug 15, 10:15PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

CytoSorbents to Host Shareholder Update Conference on Wednesday, August 21st at 4:15 p.m. Eastern
Marketwire - Wed Aug 14, 11:01AM CDT
CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company working to save lives through blood purification, today announced that management will host a shareholder update conference call on Wednesday, August 21st at 4:15 p.m. Eastern. Management kindly asks all interested participants to submit their questions to Alliance Advisors at valter@allianceadvisors.net.

CytoSorbents Provides Corporate Update and Reports Financial Results for the Period Ended June 30, 2013
Marketwire - Wed Aug 14, 7:10AM CDT
CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company commercializing its European Union approved CytoSorb(R) blood filter to treat life-threatening illnesses in the intensive care unit, provides a corporate update and reports its financial results for the three and six month period ending June 30, 2013.

CytoSorbents Selected to Present on HemoDefend(TM) at the Military Health System Research Symposium
Marketwire - Fri Jul 26, 5:00AM CDT
CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company working to save lives through blood purification, announced that it has been selected to make a presentation of its HemoDefend(TM) blood purification technology at the Military Health System Research Symposium (MHSRS), the premier U.S. scientific meeting focused on medical advances that address the unique medical needs of the warfighter.

CytoSorbents Appoints Dr. Rainer Kosanke as European Director of Scientific Affairs
GlobeNewswire - Mon Jul 08, 8:00AM CDT
CytoSorbents Corporation (OTCBB:CTSO), a critical care focused company commercializing its European Union approved CytoSorb(R) blood filter to treat life-threatening illnesses in the intensive care unit, announced today that its wholly-owned subsidiary, CytoSorbents Europe GmbH has appointed Dr. Rainer Kosanke, PhD, as European Director of Scientific Affairs.

CytoSorbents Announces Start of $1M US Army Phase II SBIR Contract and Closing of Additional Funding
GlobeNewswire - Thu Jun 27, 8:00AM CDT
CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company commercializing its European Union approved CytoSorb(R) blood filter to treat life-threatening illnesses in the intensive care unit, announced today that it has successfully completed negotiations and begun work on the previously announced $1 million Phase II SBIR (Small Business Innovation Research) contract in trauma and burn injury from the United States Army.

CytoSorbents Announces FDA Approved US Air Force Funded Human Trauma Pilot Study for Rhabdomyolysis
GlobeNewswire - Mon Jun 17, 7:00AM CDT
CytoSorbents Corporation (OTCBB:CTSO), a critical care focused company using blood purification to treat life-threatening illnesses in the intensive care unit, announced today that the United States Food and Drug Administration (FDA) has granted approval to begin a U.S.-based human pilot study using CytoSorb(R) for the treatment of rhabdomyolysis as a result of trauma under an Investigational Device Exemption (IDE). Rhabdomyolysis is caused by the massive release of myoglobin from severely injured skeletal muscle that can lead to kidney failure. The study was initiated by and will be funded by the U.S. Air Force. CytoSorbents is the official sponsor of the study, and expects the study to begin this year.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Luxury's €1.5 Trillion Market Has Moved to Memories

Updated Category News Views 93

A €1.5 trillion market that cannot grow much is still a market worth fighting over, but luxury's old playbook is looking awfully tired. Bain's 2026 view is for global luxury spending to land somewhere between flat and up 2% at constant exchange rates versus 2025. That is stability, not a victory parade. Yet the total market remains 16% to 22% above 2019 levels, and the...

Continue Reading
Exiger's CEO Honored for Military Support Excellence

Updated Category News Views 141

Recognizing Civilian and Military Leadership When you hear "recognition in the military sector," it isn't just a pat on the back. It's a whole parade of brass hats and high-flyers giving their nods. So, November 10th wasn't just any regular day—Brandon Daniels, CEO of Exiger, gets a shiny, prestigious Five-Star Award for his "extraordinary support" of our military...

Continue Reading
Envision and Tai Tam Put 45 MW Wind Bet to Work in Vietnam

Updated Category News Views 116

A wind site averaging 6.5 meters per second can look unremarkable on a map, yet that is precisely where equipment choices start separating serious developers from brochure merchants. Envision Energy and Vietnam's Tai Tam Group are taking that test on with the 45 MW Phuoc Dan wind project in Khanh Hoa Province. The arrangement follows five years of cooperation, but the...

Continue Reading
Cadence Marks $2.7 Million for St. Jude Family Care

Updated Category News Views 21

Small Wheels, Serious Purpose Tiny tricycles, flour-dusted bake-sale tables, and family pledges have pushed Cadence Education’s St. Jude partnership to $2.7 million since 2018. That number is not a flashy balance-sheet item, nor should anybody try to dress it up as one. It is the accumulated result of school communities showing up year after year, and in a sector built...

Continue Reading
Unishippers Climbs 18 Slots on 32.4% Sales Growth Run

Updated Category News Views 184

Thirty new franchise units can move the needle fast Unishippers did not inch its way up the Franchise Times Top 400; it put up a number that deserves a hard look. Sales rose 32.4% in 2025, the company added 30 franchise units, and the result was an 18-place jump to No. 81 on the 2026 ranking. In the shipping category, it was named the sales-growth leader. For a business...

Continue Reading
TGHL Eyes U.S. Battery Shift Through EnChem Merger

Updated Category News Views 112

A Policy Squeeze Is Rewriting the Battery Map Battery supply chains are getting shoved through a narrower gate, and that is exactly why this proposed deal deserves a hard look. The GrowHub Limited wants to acquire EnChem America, a Georgia-based lithium-ion battery electrolyte producer, and the timing is plainly built around Washington's push to reduce reliance on...

Continue Reading
COPD Support Program Targets a Costly Care Gap Today

Updated Category News Views 107

Breathing trouble gets shrugged off far too easily, and that casual mistake has consequences. World COPD Day puts chronic obstructive pulmonary disease back in view, with the American Lung Association emphasizing a free Lung Health Navigator program for people living with COPD, their caregivers and families. This is not flashy medicine or a miracle-cure pitch. It is...

Continue Reading
Inhibrx Ewing Data Gives Ozekibart a Real Clinical Signal

Updated Category News Views 165

Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...

Continue Reading
Italian Wine Faces U.S. Slump and New Market Openings

Updated Category News Views 75

American demand has put a cork in the easy story, and Italian wine producers cannot pretend otherwise. In the first nine months of 2026, U.S. imports of Italian wine dropped 18.4% by value. That is painful because the United States remains Italy's largest destination market by value, not some side shelf that can be ignored until conditions improve. Still, the broader U.S....

Continue Reading
Halff Elevates People and Delivery Leadership Team

Updated Category News Views 90

Infrastructure outfits rarely make much noise when they reshuffle leadership, but Halff’s Nov. 18 announcement deserves a closer look than the usual executive-title confetti. The employee-owned consulting firm has put Greg Carpenter in the chief people officer seat and named Leigh Hollis chief delivery officer. One role is aimed squarely at the human machinery; the...

Continue Reading

Top 5 Most Recently Viewed Articles

Venus Concept Strengthens Financial Position with Debt Exchange

Updated Category News Views 173

Venus Concept Optimizes Capital Structure through Debt Exchange Venus Concept Inc. is making waves in the medical aesthetic technology industry with its recent strategic financial decision. The company, known for its innovative solutions, has successfully exchanged $11 million worth of subordinated convertible notes for 379,311 shares of Series Y preferred stock. This...

Continue Reading
Understanding the Recent Decline of Gentex Corporation Stock

Updated Category News Views 284

Why Is Gentex Corporation Stock Down? Gentex Corporation (NASDAQ:GNTX) shares have recently faced a decline after revealing third-quarter earnings that fell short of expectations. The drop can be largely attributed to lower-than-expected earnings per share (EPS) and sales figures. Quarterly Earnings Performance For the third quarter, Gentex reported adjusted earnings of...

Continue Reading
Elliott Pressures Northern Star: Board Shake-Up Needed

Updated Category News Views 59

Reckoning Time for Northern Star Resources Well, it's about time someone rattled the cage at Northern Star. Elliott Management, never one to sit on its laurels, is clapping back at the board with a stern letter, raising eyebrows and hopes for a shake-up. They're putting their 5.6% stake to work, backing their talk with a lineup of heavyweight board candidates. The message...

Continue Reading
CBD's Role in Supporting World Cup Soccer Players

Updated Category News Views 60

World Cup Sparks Focus on Player Recovery An event like the FIFA World Cup doesn't just put its spotlight on dazzling goals and nail-biting penalty shootouts; it throws the grueling demands placed on players into sharp relief. With fixtures spread across sprawling global schedules, these athletes barely get time to breathe between matches. Rest Rules Let Players Recharge...

Continue Reading
Middlefield Canadian Income PCC: Major Holdings Announcement

Updated Category News Views 185

Overview of Middlefield Canadian Income PCC Holdings Middlefield Canadian Income PCC is actively engaged in managing major holdings and ensuring transparency in its share structure. The company recently issued a comprehensive notification, detailing the current shareholding status and changes in voting rights, importantly reflecting the interests of its shareholders....

Continue Reading